1.Effect of Nicergoline for chronic cerebrovascular insufficiency: a meta analysis
Yujuan JIA ; Yuli HOU ; Jingtian HOU
Chinese Journal of Geriatrics 2015;34(10):1141-1144
Objective To systematically review the efficacy and safety of nicergoline on chronic cerebrovascular insufficiency (CCVI).Methods Databases including the Cochrane Library,PubMed,CNKI,VIP and WanFang Date were electronically searched for relevant randomized controlled trails (RCTs) which studied the effectiveness and safety of Nicergoline on chronic cerebrovascular insufficiency.Two reviewers independently screened literature according to the inclusion and exclusion criteria,extracted data,and assessed the methodological quality.Metaanalysis was performed by using RevMan 5.2 software.Results Totally 9 studies involving 1 030 patients were included.The meta-analysis results showed that,compared with conventional treatment alone,the Nicergoline group was superior in improving the velocity of middle cerebral artery(MCA) in both systolic(MD=16.43,95%CI:10.39-22.46) and the late diastolic (MD=11.48,95%CI:5.34-17.63).Besides,Nicergoline significantly improved the pulse index (PI) of MCA (MD=-0.37,95%CI:-0.48--0.26).Likewise,it obviously improved the velocity in both systolic (MD=11.23,95%CI:6.10-16.35),the late diastolic (MD=8.80,95%CI:5.20-12.40) and the PI of vertebral artery (VA) (MD=-0.38,95%CI:-0.47--0.28).The remission rate of the nicergolinegroup was higher than that of the control group (OR=3.93,95% CI:2.66-5.81).Drug-related adverse reactions were not reported in included studies.Conclusions Nicergoline shows a certain efficacy on CCVI without obvious adverse reactions.
2.Comparison of Excel and CMRtools in Evaluating Myocardium and Liver T2* for Iron Overload
Yanzhen HOU ; Yi LEI ; Yuli WANG ; Haiyan SONG ; Xinping SHEN ; Yupei MA
Chinese Journal of Medical Imaging 2015;(9):710-713
PurposeTo assess the level of agreement and interchangeability among Excel and CMRtools (2012) for calculation of T2* values in iron overload.Materials and Methods T2* images in 27 cases withβ-thalassemia major were imported into CMRtools (2012). The regions of interest (ROI) were drawn and interference signal removed to obtain T2* values. The T2* images were also measured using default MR software and manually entered into Excel to obtain T2* values after removal of the interference signal. The agreement between the two methods in calculating T2* values was compared.Results For 27 patients withβ-thalassemia major, 10 cases showed myocardial iron overload. 25 cases had liver iron overload. The T2* values from two methods were not statistically significant (t=-0.152 and-0.691,P>0.05) for the liver.Conclusion There is good agreement and interchangeability between Excel and CMRtools (2012) in calculating T2* values. Excel can be used clinically to evaluate iron overload.
3.Different calcium channel blockers prevent stroke in hypertensive patients: a network meta-analysis of randomized controlled trials
Kai WANG ; Yujuan JIA ; Yuli HOU
International Journal of Cerebrovascular Diseases 2019;27(4):260-266
Objective To systematically evaluate the effectiveness and safety of different calcium channel blockers (CCBs) in preventing stroke in hypertensive patients.Methods PubMed,Cochrane Library,Embase,Wanfang,CNKI,CBM,and other databases were comprehensively retrieved,and the randomized controlled trials of different CCBs in the prevention of stroke in hypertensive patients were collected.The retrieval time was from the establishment of the databases to November 5,2018.The languages were limited to Chinese and English.The literature screening,study inclusion,information extraction,and quality evaluation were independently conducted by two professional reviewers.A network diagram was drawn using Stata 13.0,and a meta-analysis of the included studies was performed using the Bayes model of the GeMTC 1.4.3 software.Results A total of 12 studies with 58 468 patients were enrolled.Network metaanalysis showed that nitrendipine (odds ratio 0.63,95% confidence interval 0.44-0.89) and nifedipine (odds ratio 0.68,95% confidence interval 0.46-0.92) were statistically significant in reducing the incidence of stroke.Other CCBs were not statistically significant in reducing the incidence of stroke,but had clinical differences.For the effectiveness of applying different CCBs to reduce the incidence of stroke,lacidipine should be preferred,followed by amlodipine,nitrendipine,nifedipine,and felodipine.However,there were no statistically significant differences in the effectiveness of different CCBs in preventing stroke.Conclusion Different CCBs can effectively reduce the incidence of stroke.In terms of specific drug types,lacidipine should be considered first,followed by amlodipine,nitrendipine,nifedipine,and felodipine.
4.Immunological characteristics of tumor antigen specific T cells and their possible mechanisms in hepatocellular carcinoma
Yuli HOU ; Yonghong ZHANG ; Yan ZHAO
Journal of Clinical Hepatology 2016;32(6):1220-1224
Hepatocellular carcinoma (HCC) is a major health problem around the world and its morbidity is increasing year by year. HCC has a low rate of early diagnosis and advanced HCC has a low survival rate. Therefore, the diagnosis and treatment of HCC has attracted great attention, and tumor specific T cell immunity plays an important role in it. This article describes the immunological characteristics of seven HCC-associated antigen specific T cells, i.e., alpha fetal protein, phosphatidylinositol proteoglycan-3, NY-ESO-1, SSX-2, melanoma antigen gene A, telomerase reverse transcriptase, and HCC-associated antigen-519/target protein xklp-2, and analyzes the possible mechanisms which affect antigen specific T cell immunity from the aspects of regulatory T cells, myeloid-derived suppressor cells, antigen presenting and processing, inhibitory receptors, and CD4+T cells.
5.Preliminary exploration of reproductive health issues for adult dysaudia female
Yuli ZANG ; Xiaohong HOU ; Yulin WANG ; Jing LI ; Xingbo DUAN ; Chunlan TONG ; Nan ZHU ; Yiqiao SHEN ; Kuichang YUAN ; Xiaoqin MENG ; Qiang CHENG ; Fenglan LOU
Chinese Journal of Practical Nursing 2008;24(28):63-64
Objective This study aimed to explore issues about dysandia female during pregnancy,peripartum and contraception and to supply reference for their reproductive health improvement. Methods Purposive sampling strategy was used. With the aid of an interview guide, 12 dysaudia women who met inclu-sion and exclusion criteria were invited to be interviewed. Interviews were recorded, validated and then ana-lyzed. Results Four themes were generated, limited knowledge, passive information acquisition, total depen-dence on family and reluctant to talk about contraception. Total dependence on family was noticeable during pregnancy and peripartum. Though little was known about health protection related to pregnancy, peripartum and contraception, participants were passive at seeking for relevant information. Conclusions Deaf women may experience more threats to reproductive health in relation to pregnancy, peripartum and contraception that they require more guidance and assistance.
6.Preliminary study on the changes of Pole2 expression in the lymphocytes with aging as well as in the age-related diseases
Chi ZHANG ; Yuli HOU ; Peichang WANG
Chinese Journal of Laboratory Medicine 2021;44(10):943-947
Objective:To explore the age-related changes of Pole2 expression levels in peripheral blood lymphocytes of healthy people, and analyze the differences of Pole2 expression levels in peripheral blood lymphocytes of four common senile disease patients between normal peers.Methods:Healthy people and patients in the physical examination center of Xuanwu Hospital of Capital Medical University from December 2018 to December 2019 were selected as the research objects, the mRNA and protein level of Pole2 in heathy individual as 20-29,30-39,40-49,50-59,60-69,70-79 y were checked by RT-PCR and Western blot,and the age-related curve was drew. The mRNA and protein expression levels of Pole2 were also detected in the peripheral blood lymphocytes of patients of DM,CHD,AD,CVD. And the deviation with healthy people of the same age was analyzed from one way ANOVA and repeated measurement were used to compare the mean of multiple groups.Results:The mRNA and protein levels of Pole2 increased in the lymphocytes of healthy people at 20-29 y and 50-59 y grouy, and decreased after 60-69 y and 70-79 y ( P<0.001). The Pole2 levels of mRNA and protein in the lymphocytes of patients of CHD,AD,DM and CVD cerebral atherosclerosis were significantly higher than that of healthy people of the same age. Moreover, the Pole2 level of lymphocytes of AD patients was significantly higher than that of other patient groups ( P<0.001). Conclusion:The expression level of Pole2 in peripheral blood lymphocytes increases with age before the age of 60 years old and decreases with age after 60 years old ;and the expression in four common senile diseases was higher than that in normal people.
7.Recent advance in imaging features of anti- N-methyl- D-aspartic acid receptor encephalitis
Qian PANG ; Zan DONG ; Xiaoyang CHAI ; Fei HU ; Keyu YANG ; Yuli HOU ; Jing WANG ; Jie WANG
Chinese Journal of Neuromedicine 2020;19(6):645-648
Anti- N-methyl- D-aspartic acid (NMDA) receptor encephalitis is an autoimmune encephalitis mediated by anti-NMDA receptor antibody. At present, the diagnosis of the disease depends mainly on typical clinical symptoms and detection of specific antibodies in cerebrospinal fluid. Early and timely treatment can curb the disease progression and improve the prognosis of the disease. However, because of the atypical clinical manifestations of patients and long waiting time for antibody detection, early identification is difficult. Imaging equipment is more popular in primary hospitals in China, and it is easier to perform imaging examination for suspected patients in the early stage; therefore, this article aims to review the imaging characteristics and current imaging research progress of anti-NMDA receptor encephalitis in recent years, so as to improve clinicians' understanding and early recognition of this disease.